Anbio Biotechnology (NNNN) Equity Ratio (2023 - 2025)

Anbio Biotechnology's Equity Ratio history spans 3 years, with the latest figure at 1.0 for Q4 2025.

  • Quarterly Equity Ratio rose 9.74% to 1.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.0 through Dec 2025, up 9.74% year-over-year, with the annual reading at 1.0 for FY2025, 9.74% up from the prior year.
  • Equity Ratio came in at 1.0 for Q4 2025, up from 0.91 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 1.0 in Q4 2025 to a low of 0.91 in Q4 2024.
  • The 3-year median for Equity Ratio is 0.94 (2023), against an average of 0.95.
  • Year-over-year, Equity Ratio decreased 3.06% in 2024 and then rose 9.74% in 2025.
  • Anbio Biotechnology's Equity Ratio stood at 0.94 in 2023, then fell by 3.06% to 0.91 in 2024, then rose by 9.74% to 1.0 in 2025.
  • Per Business Quant, the three most recent readings for NNNN's Equity Ratio are 1.0 (Q4 2025), 0.91 (Q4 2024), and 0.94 (Q4 2023).